Accenture Gains, Synopsys Rises, Moderna Tumbles as Citi Advises Selling Following 600% Rally |...
Community Score: 50% | 25 views | 2w
0 community ratings: null thumbs up, null thumbs down
On this episode of Stock Movers: - Accenture (ACN) shares rise. Accenture reported revenue for the period came in at $18.7 billion, up 7% from the year prior, beating Bloomberg-compiled analyst estimates of $18.04 billion. The company reported $22.2 billion of new bookings, beating the roughly $20 billion analysts had estimated, and announced separate deals with Alphabet Inc.'s Google Cloud, Anthropic PBC and Amazon.com Inc.'s web services unit. - Synopsys (SNPS) shares are up 9% with analysts positive on the maker of electronic design automation software in the wake of an investor day event where it gave long-term targets that are seen as strong. - Moderna (MRNA) shares tumble. A Citigroup analyst recommended selling the stock, saying its current valuation is “unjustifiable” following an outsized rally. The analyst believes the re-rating of the stock reflects successful expansion in many tumor types and unrealistic implied sales, and that the melanoma win for the vaccine does not bro
Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast
More from Bloomberg Podcasts
- Follow the Money All the Way to Carney's Canada — Score: 50%
- Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
- Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
- We hear you! | Bloomberg Hot Pursuit! — Score: 50%
- Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
- Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%